We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
126
McDonald's
MCD
$194B
$672K 0.1%
2,300
– –
WSC icon
127
WillScot Mobile Mini Holdings
WSC
$4.15B
$641K 0.1%
23,400
– –
GE icon
128
GE Aerospace
GE
$382B
$618K 0.09%
2,400
– –
PFE icon
129
Pfizer
PFE
$152B
$606K 0.09%
25,000
-8,300
-25% -$194K
UYSCU
130
UY Scuti Acquisition Corp Units
UYSCU
$594K 0.09%
57,800
– –
AMD icon
131
Advanced Micro Devices
AMD
$774B
$582K 0.09%
4,100
– –
PRLB icon
132
Protolabs
PRLB
$2.16B
$581K 0.09%
14,500
– –
GSRTR
133
DELISTED
GSR III Acquisition Corp Right
GSRTR
$567K 0.09%
+83,000
New +$310K
LWACU
134
LightWave Acquisition Corp Units
LWACU
$557K 0.09%
+55,400
New +$556K
SPB icon
135
Spectrum Brands
SPB
$2.02B
$557K 0.09%
10,500
+2,000
+24% +$119K
SATX
136
DELISTED
SatixFy Communications
SATX
$555K 0.09%
+189,583
New +$458K
TTEC icon
137
TTEC Holdings
TTEC
$84.2M
$555K 0.09%
115,350
-69,400
-38% -$318K
SBGI icon
138
Sinclair Inc
SBGI
$989M
$549K 0.08%
39,725
– –
GTX icon
139
Garrett Motion
GTX
$5.43B
$547K 0.08%
52,082
-103,350
-66% -$1.04M
ANSC
140
Agriculture & Natural Solutions Acquisition Corp
ANSC
$476M
$541K 0.08%
49,900
– –
BCV
141
Bancroft Fund
BCV
$140M
$529K 0.08%
28,000
– –
GDEN
142
DELISTED
Golden Entertainment
GDEN
$527K 0.08%
17,900
– –
AMAT icon
143
Applied Materials
AMAT
$417B
$513K 0.08%
2,800
– –
WOW
144
DELISTED
WideOpenWest
WOW
$511K 0.08%
125,953
– –
LBTYA icon
145
Liberty Global Class A
LBTYA
$3.48B
$475K 0.07%
47,500
– –
MU icon
146
Micron Technology
MU
$981B
$468K 0.07%
3,800
– –
SDS icon
147
ProShares UltraShort S&P500
SDS
$371M
$461K 0.07%
+5,540
New +$550K
STHO icon
148
Star Holdings Shares of Beneficial Interest
STHO
$115M
$461K 0.07%
59,050
– –
TSM icon
149
TSMC
TSM
$2.19T
$453K 0.07%
2,000
+500
+33% +$92.6K
MX icon
150
Magnachip Semiconductor
MX
$142M
$453K 0.07%
113,725
– –
4 5
6
7 8

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.